Iferanserin

DB11686InvestigationalSmall molecule

Iferanserin has been investigated for the treatment of Hemorrhoids.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 2A
Curator reviewed
Formula / weight: C₂₃H₂₈N₂O · 348.49 g/mol (avg)

Resolves to

Compound

Structure

InChIKeyUXIPFQUBOVWAQW-UEBLJOKOSA-NSMILESCN1CCCC[C@H]1CCC1=CC=CC=C1NC(=O)\C=C\C1=CC=CC=C1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

680Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Iferanserin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.